Page 2 - மெரிடியன் மருத்துவ தொழில்நுட்பங்கள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published July 16. 2021 12:44AM | Updated July 16. 2021 1:02AM Get the weekly rundown Email Submit KANSAS CITY, Kan. (AP) Pfizer Inc. and two of its subsidiaries have agreed to pay $345 million under a proposed settlement to resolve lawsuits over EpiPen price hikes. In documents filed Thursday in federal court in Kansas City, Kan., the New York-based Pfizer and its subsidiaries Maryland-based Meridian Medical Technologies Inc. and Tennessee-based King Pharmaceuticals asked the court to grant preliminary approval to the settlement, Kansas City s NPR station KCUR-FM reported. The litigation dates to 2016, when numerous class-action lawsuits were filed around the country alleging that the companies engaged in anticompetitive conduct related to EpiPen. The cases were transferred to the Kansas court because of its centralized location.

United statesKansas cityWest virginiaDaniel crabtreeJoe manchinHeather breschMeridian medical technologies incKing pharmaceuticalsPfizer incNew york based pfizerMaryland based meridian medical technologiesTennessee based king pharmaceuticalsJudge daniel crabtreeஒன்றுபட்டது மாநிலங்களில்கன்சாஸ் நகரம்மேற்கு வர்ஜீனியா